March 25th 2024
Jeffrey Reese, president at Reese Pharmaceutical, discusses what sets ColoTest apart from other at-home colorectal cancer screening tests.
Risks and Liabilities in Pharmacy Practice
1.0 Credit / Law
View More
Optimizing the Use of Targeted Therapies for the Treatment of ROS1-Rearranged and KRAS-Mutant Non−Small Cell Lung Cancer
1.0 Credits / Oncology
View More
An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC
2 Credits / Oncology, Pulmonology/Respiratory
View More
Exploring the New Standard of Care for the Frontline Treatment of Non-Small Cell Lung Cancer: A Focus on Immunotherapy
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell Lymphoma: Insights and Application for Managed Care
1.0 Credit / Oncology
View More
CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care
1.5 Credits / Hematology, Oncology
View More
Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL
2.0 Credits / Hematology, Oncology
View More
Precision Oncology in Practice: Transforming Non–Small Cell Lung Cancer Care Through Advanced Biomarker Testing
April 4, 2024 | 2:25 PM ET
View More
Navigating the Use of Bispecific Antibodies in Non-Hodgkin Lymphoma: Solutions to Enhance Community-Based Care
April 4, 2024 | 11:50 AM ET
View More
Finding Balance Between Advancement and Application: A Guide for Community Oncology Pharmacists on CAR T-Cell Therapies and Bispecific Antibodies in Multiple Myeloma
April 4, 2024 | 11:00 AM ET
View More
Ensuring the Safe, Effective, and Equitable Care of Patients With Advanced Endometrial Cancer: Strategies for Oncology Pharmacists
April 4, 2024 | 1:35 PM ET
View More
COA Virtual Broadcasts
April 4-5, 2024
View More
Navigating Myelofibrosis: Tailored Treatments and Holistic Patient Support
April 5, 2024 | 11:00 AM ET
View More
Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia
1.5 Credits / Hematology, Oncology
View More
Evidence and Managed Care Considerations for the Use of Novel Immunotherapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
1.5 Credits / Oncology
View More
Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma
1.5 Credits / Hematology, Oncology
View More
New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes
1.5 Credits / Hematology, Oncology
View More
Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens
1.0 Credit / Hematology, Oncology
View More
Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful Role
1.0 Credit / Hematology, Oncology
View More
Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based Regimens
1.0 Credit / Hematology, Oncology
View More
Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care
1.0 Credit / Hematology, Oncology
View More
Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy
1.0 Credit / Hematology, Oncology
View More
Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed Initiatives
1.0 Credit / Hematology, Oncology
View More
Optimizing Safe Use of Antibody-Drug Conjugates in Solid Tumors Through Pharmacist Interventions
1.0 Credit / Oncology
View More
Navigating Current and Emerging Treatment Options for Myelofibrosis After Frontline Failure
1.0 Credit / Oncology
View More
Optimizing Treatment of Early-Stage Breast Cancer and the Pharmacist’s Role in Managing Targeted Therapies
1.5 Credits / Oncology
View More
Targeted Therapies for Non-Small Cell Lung Cancer With ROS1 or KRAS Mutations and the Impact of Pharmacists’ Care
1.0 Credit / Oncology, Pulmonology/Respiratory
View More
Enhancing Care for Patients With Endometrial Cancer Through Pharmacist Interventions
1.0 Credit / Oncology, Women’s Health
View More
Clinical Updates and Strategies for Optimizing Use of Bispecific Antibodies in Hematologic Malignancies
1.0 Credit / Oncology
View More
Investigating Novel Strategies for the Treatment of Metastatic Small Cell Lung Cancer After Frontline Treatment Failure
1.0 Credit / Oncology
View More
Personalized Survivorship Plans for Colon Cancer Patients Receiving Adjuvant Chemotherapy
October 23rd 2023Survivorship care for patients with colon cancer should include comprehensive coordination between oncologists, specialists, and primary care providers and include psychological and economic factors in addition to standard health recommendations.
Race, Ethnicity Data in Screening Model Could Reduce Lung Cancer Screening Disparities
September 21st 2023The ‘life-years gained from screening–computed tomography’ lung cancer screening model is recommended by the American College of Chest Physicians for personalizing patients’ shared decision-making in screening for lung cancer.
High BMI in Breast Cancer Patients Linked With Increased Cardiotoxicity During Chemotherapy
August 9th 2023A recent study being presented at the American College of Cardiology Latin America 2023 conference found the prevalence of cardiotoxicity among patients with breast cancer undergoing chemotherapy was 11.94%.